The Difference Between Stabilization and Crosslinking
Transcription
The Difference Between Stabilization and Crosslinking
The Difference Between Stabilization and Crosslinking Katarina Edsman, Åke Öhrlund, Cecilia Sturesson, Lars Nord, Anne Helander Kenne and Jacques Näsström Q-Med AB, Seminariegatan 21, SE-752 28 Uppsala, Sweden. Objective Conclusions Conclusions The objective of this study was to investigate if there are measurable differences between hyaluronic acid (HA) dermal fillers manufactured using the NASHA™ process and products using other crosslinking processes. Introduction Most hyaluronic acid (HA) dermal fillers are chemically modified with crosslinkers to improve the mechanical properties and the duration in vivo. The crosslinking can be made in many different ways. The most common method is traditional crosslinking where most of the gel strength is achieved by introducing chemical (synthetic) crosslinks. Alternatively there is stabilization where a small amount of synthetic crosslinks stabilize the natural crosslinks (entanglements), see Figure 1. Entanglement of HA chains (natural crosslinks) Synthetic crosslink a + HA Reagent b shows the differences between the HA-dermal fillers manufactured with the NASHA™ process and products manufactured with other crosslinking processes. • A high modification efficiency (MoE) was obtained for Restylane products manufactured using the NASHA™ process, which preserves entanglements that contribute to the gel strength. • NASHA™ technology is unique since it combines a strong gel and a minimal modification of the HA. Results + Reagent • The modification efficiency (MoE) is a measurable quantity that HA c Figure 1. a) Synthetic and natural crosslinks (entanglements). b) Traditional crosslinking processes result in a gel with numerous chemical crosslinks and few natural entanglements. c) Stabilization gives a low number of chemical crosslinks and a large number of natural entanglements. The modification efficiency (MoE) is shown in Figure 2. All the examined HA-fillers have MoE values below one, whereas the Restylane products have MoE values over four. The NASHA stabilization process used for manufacturing the Restylane products results in a very high gel strength for each modification compared to the other HA-fillers. It seems like the NASHA™ process is unique in preserving entanglements when compared to the other processes used for manufacturing the HA-fillers examined in this study. A similar result can be seen in Figure 3 using another measure of the gel strength, G*. The Restylane products have a higher gel strength and a lower degree of modification compared to the other HA-fillers in this study. Degree of Modification (MoD) The degree of modification (MoD) is defined as the ratio of moles (number of molecules) of linked crosslinker to moles of HA-disaccharides. To preserve biocompatibility of the HA molecules the modification should preferably be kept at a minimum. Crosslinker HA-disaccharide Gel strength The strength of a gel is dependent on the total number of crosslinks (both chemical crosslinks and natural entanglements). The stronger the gel the better is the lifting capacity. Figure 2. The modification efficiency (MoE) for different HA-fillers. In this study we have used two measures of gel strength, Cmin and G*: Cmin is the concentration of HA in the fully swollen gel in an excess of solvent. Stronger gels swell less and have a higher value for Cmin. 15 14 G* is the complex modulus measured by rheology. It is a measure of the total resistance to deformation. Stronger gels have a higher resistance to deformation and a higher value for G*. 13 Modification efficiency 2 5 The modification efficiency (MoE) is a measure of the gel strength achieved for each introduced crosslinker molecule. MoE can be calculated from the gel strength, Cmin (in mg/ml) and the degree of modification, MoD (in %). MoE= Cmin MoD 9 4 The strength of the gel Degree of modification Materials 12 3 1 8 10 11 Figure 3. The gel strength measured as the total resistance to deformation, G* plotted against the degree of modification (MoD). Sample numbering as in Table 1. Methods Table 1. Investigated HA-filler products # Produkt Lot No Manufacturer 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Teosyal™ Deep Lines Teosyal™ Ultra Deep Esthelis BasicTM Fortelis ExtraTM Stylage MTM Stylage LTM Stylage XLTM Juvéderm® Ultra 2 Juvéderm® Ultra 3 Juvéderm® Ultra 4 Princess Filler Renofill Perfectly Volume Restylane Touch™ Restylane® Restylane PerlaneTM TS27-083502B TSU-082903B 311103/3 510063/2 EMB090061 ELB083301 EXC083231 X24L506559 X30L509376, X30L504649 S30L482804 903015/2, 903006/2, 903008/1 410065/2 10254 10368 10312 Teoxane, Switzerland Teoxane, Switzerland Anteis, Switzerland Anteis, Switzerland Laboratories Vivacy, France Laboratories Vivacy, France Laboratories Vivacy, France Allergan, France Allergan, France Allergan, France Croma Pharma GmbH, Austria Laboratories Renophase, France Q-Med AB, Sweden Q-Med AB, Sweden Q-Med AB, Sweden Determination of MoD Gel filler samples were washed by 0.9% NaCl and filtered on a 0.22 micrometer filter. The washed gel samples were completely enzyme digested with Chondroitinase AC in deuterated water and 1H NMR spectra were recorded at 400 MHz from the resulting digests. The degree of modification was determined by integrating the signal from the N-acetyl group in HA and one signal from the BDDE crosslinker. The ratio between the integrals for these two signals (crosslinker/ HA NAc) gives the degree of modification after correction for the number of protons responsible for each signal. Determination of Cmin Cmin is calculated as the concentration of HA in the product multiplied by the gel content and divided by the swelling factor. The gel content is the fraction of HA that cannot pass through a 0.22 micrometer filter when filtering a diluted suspension of the product. The swelling factor is calculated as V/Vo where Vo is the initial volume of the gel and V is the volume of the fully swollen gel in 0.9% NaCl. Determination of G* The viscoelastic properties were measured on an Anton Paar MCR 301 rheometer using the parallel plate measuring system using a gap of 1mm. G* was measured in a frequency sweep within the linear viscoelastic range determined by a strain sweep and evaluated at 0.1Hz. 8th Anti-aging Medicine World Congress (AMWC) Monte-Carlo, Monaco - April 8-9-10, 2010